Cargando…

Impact of implementing a vancomycin protocol to reduce kidney toxicity: A comparative study

Introduction: Vancomycin is a frequently used antibiotic for treating severe infections caused by multidrug-resistant, Gram-positive pathogens. To ensure its effectiveness and minimize the risk of nephrotoxicity, safe administration and dose monitoring are crucial. Understanding the impact of vancom...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baiocco, Graziella Gasparotto, Greiner, Stephanie, Rosa, Mário Borges, Flores, Cecília Dias, Barros, Helena M. T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10569023/ https://www.ncbi.nlm.nih.gov/pubmed/37841919 http://dx.doi.org/10.3389/fphar.2023.1154573

Ejemplares similares

Risk Scoring System for Vancomycin-Associated Acute Kidney Injury
por: Kim, Jee Yun, et al.
Publicado: (2022)

Optimizing Vancomycin Dosing in Chronic Kidney Disease by Deriving and Implementing a Web-Based Tool Using a Population Pharmacokinetics Analysis
por: Dorajoo, Sreemanee Raaj, et al.
Publicado: (2019)

Vancomycin Associated Acute Kidney Injury: A Longitudinal Study in China
por: Kunming, Pan, et al.
Publicado: (2021)

Nephroprotective potential of Polyalthia longifolia roots against vancomycin-induced renal toxicity in experimental animals
por: Das, Kuntal, et al.
Publicado: (2023)

Population Pharmacokinetics of Vancomycin in Kidney Transplant Recipients: Model Building and Parameter Optimization
por: Ma, Kui-fen, et al.
Publicado: (2020)

Model-Informed Precision Dosing of Vancomycin in Hospitalized Children: Implementation and Adoption at an Academic Children’s Hospital
por: Frymoyer, Adam, et al.
Publicado: (2020)

The Role of Urinary Biomarkers as Diagnostic and Prognostic Predictors of Acute Kidney Injury Associated With Vancomycin
por: Sampaio de Souza Garms, Durval, et al.
Publicado: (2021)

Analysis of a machine learning–based risk stratification scheme for acute kidney injury in vancomycin
por: Mu, Fei, et al.
Publicado: (2022)

Vancomycin associated acute kidney injury in patients with infectious endocarditis: a large retrospective cohort study
por: Kunming, Pan, et al.
Publicado: (2023)

Fusogenic Liposomes Increase the Antimicrobial Activity of Vancomycin Against Staphylococcus aureus Biofilm
por: Scriboni, Andreia Borges, et al.
Publicado: (2019)

Population Pharmacokinetics of Vancomycin in Pregnant Women
por: Goyal, Rahul K., et al.
Publicado: (2022)

AI Models to Assist Vancomycin Dosage Titration
por: Wang, Zhiyu, et al.
Publicado: (2022)

Model-informed precision dosing in vancomycin treatment
por: Yoon, Sukyong, et al.
Publicado: (2023)

Population pharmacokinetic model of vancomycin in postoperative neurosurgical patients
por: Wei, Shifeng, et al.
Publicado: (2022)

The OBTAINS study: A nationwide cross-sectional survey on the implementation of extended or continuous infusion of β-lactams and vancomycin among neonatal sepsis patients in China
por: Zhou, Pengxiang, et al.
Publicado: (2022)

Metabolomics Reveals the Mechanisms for the Pulmonary Toxicity of Siegesbeckia orientalis L. and the Toxicity-Reducing Effect of Processing
por: Jiang, Ting, et al.
Publicado: (2021)

Erratum: The OBTAINS study: A nationwide cross-sectional survey on the implementation of extended or continuous infusion of β-lactams and vancomycin among neonatal sepsis patients in China
por: Frontiers Production Office,
Publicado: (2022)

Dose optimization of vancomycin in obese patients: A systematic review
por: Elrggal, Mahmoud E., et al.
Publicado: (2023)

Mequindox-Induced Kidney Toxicity Is Associated With Oxidative Stress and Apoptosis in the Mouse
por: Liu, Qianying, et al.
Publicado: (2018)

In vivo / in vitro Correlation of Pharmacokinetics of Gentamicin, Vancomycin, Teicoplanin and Doripenem in a Bovine Blood Hemodialysis Model
por: Vossen, M G, et al.
Publicado: (2021)

Population Pharmacokinetics of Vancomycin in Chinese ICU Neonates: Initial Dosage Recommendations
por: Li, Zhi-ling, et al.
Publicado: (2018)

External Evaluation of Vancomycin Population Pharmacokinetic Models at Two Clinical Centers
por: Liu, Yi-Xi, et al.
Publicado: (2021)

Population Pharmacokinetics of Vancomycin and Meropenem in Pediatric Extracorporeal Membrane Oxygenation Support
por: Zylbersztajn, Brenda, et al.
Publicado: (2021)

Pharmacokinetics of Intraperitoneal Vancomycin and Amikacin in Automated Peritoneal Dialysis Patients With Peritonitis
por: Falbo dos Reis, Pâmela, et al.
Publicado: (2021)

Serum Creatinine and Serum Cystatin C are Both Relevant Renal Markers to Estimate Vancomycin Clearance in Critically Ill Neonates
por: Leroux, Stéphanie, et al.
Publicado: (2021)

Identification of the Toxicity Pathways Associated With Thioacetamide-Induced Injuries in Rat Liver and Kidney
por: Schyman, Patric, et al.
Publicado: (2018)

Cajanin Stilbene Acid Inhibited Vancomycin-Resistant Enterococcus by Inhibiting Phosphotransferase System
por: Tan, Shengnan, et al.
Publicado: (2020)

Predicted Vancomycin Dosage Requirement in Patients With Hematological Malignancies and Dosage Dynamic Adjustment
por: Song, Xiangqing, et al.
Publicado: (2022)

Implementation of pharmacogenetic testing in oncology: DPYD-guided dosing to prevent fluoropyrimidine toxicity in British Columbia
por: Wu, Angela, et al.
Publicado: (2023)

Association of NQO2 With UDP-Glucuronosyltransferases Reduces Menadione Toxicity in Neuroblastoma Cells
por: Chhour, Monivan, et al.
Publicado: (2021)

Coadministration of bedaquiline and pyrifazimine reduce exposure to toxic metabolite N-desmethyl bedaquiline
por: Ding, Yangming, et al.
Publicado: (2023)

Dose Tailoring of Vancomycin Through Population Pharmacokinetic Modeling Among Surgical Patients in Pakistan
por: Munir, Muhammad Muaaz, et al.
Publicado: (2021)

Evaluation of vancomycin pharmacokinetics in patients with augmented renal clearances: A randomized clinical trial
por: Sahraei, Zahra, et al.
Publicado: (2022)

Kidney Organoid and Microphysiological Kidney Chip Models to Accelerate Drug Development and Reduce Animal Testing
por: Chen, Wei-Yang, et al.
Publicado: (2021)

Systemic Toxicity of Intraperitoneal Vancomycin
por: Kumar, Teerath, et al.
Publicado: (2016)

Nano-Neurotheranostics: Impact of Nanoparticles on Neural Dysfunctions and Strategies to Reduce Toxicity for Improved Efficacy
por: Vinod, Chiluka, et al.
Publicado: (2021)

Clinical Implementation of DPYD Pharmacogenetic Testing to Prevent Early-Onset Fluoropyrimidine-Related Toxicity in Cancer Patients in Switzerland
por: Begré, Ursina B. M., et al.
Publicado: (2022)

Augmented Renal Clearance in Severe Infections—An Important Consideration in Vancomycin Dosing: A Narrative Review
por: Xiao, Qile, et al.
Publicado: (2022)

Pharmacokinetic assessment of vancomycin in critically ill patients and nephrotoxicity prediction using individualized pharmacokinetic parameters
por: Ghasemiyeh, Parisa, et al.
Publicado: (2022)

Systematic review of efficacy, safety and pharmacokinetics of intravenous and intraventricular vancomycin for central nervous system infections
por: Liu, Shu-Ping, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_i5nj7379q177n0mdfq5f174fak